RxDoctor Payments Data

Holly Kramer, MD

Nephrology · Maywood, ILNPI 1003893975

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $79,835 of the $89,385 with a category attached, or 89.3%. Bayer accounts for 86.7% of it on its own, with 11 other manufacturers making up the rest. Among nephrology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$89,385in general payments, 2019–2025

Across 78 payments — averaging $1145.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$78K
  • AstraZeneca$5K
  • Vifor Pharma, Inc.$4K
  • Eli Lilly$2K
  • Roche Products Limited$190
  • Medtronic$93
  • plus $150 from 6 others
$26,670in research payments, 2019–2025

Across 4 payments — averaging $6667.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$27K

What the payments were for

  • Consulting fees$79,83589%
  • Speaking & faculty fees$3,2404%
  • Travel & lodging$4,8645%
  • Food & beverage$1,3462%
  • Education$1000%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$89,385 in reported general payments places this provider in the 95th percentile of 524 nephrology providers in Illinois.

See all nephrology providers in Illinois

Medicare billing

Part B allowed, 2024
$11,157
Medicare patients
55
Services billed
113

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin13$7,220
Calcitriol37$695
Torsemide32$675
Chlorthalidone35$485
Pentoxifylline12$399
Nifedipine ErNifedipine11$381
Spironolactone15$343
Losartan Potassium22$121
Lisinopril13$93
Amlodipine Besylate19$88
Carvedilol15$72
Allopurinol18$62
Furosemide14$48

Paid to pharmacies, not to this prescriber.

Other nephrology in Maywood

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →